{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:28:18Z","timestamp":1786609698768,"version":"build-2736575974"},"reference-count":180,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most common chronic liver diseases worldwide, affecting more than one-third of adults and imposing a substantial hepatic and systemic metabolic burden. With the continuing rise in obesity, type 2 diabetes mellitus, and related metabolic abnormalities, the prevalence of MASLD is expected to keep increasing. This review summarizes MASLD from the overarching perspective of gut-liver axis dysregulation, focusing on alterations in gut microbial composition and function, intestinal barrier injury, disturbances in microbiota-derived metabolites, and gut microbiota-associated epigenetic and immune dysregulation during disease initiation and progression. It further integrates the overall significance of these changes in the evolution of MASLD. Finally, potential therapeutic strategies represented by fecal microbiota transplantation and natural products are briefly discussed, suggesting that targeting the gut microbiota and its related networks may provide new opportunities for MASLD prevention and treatment.<\/jats:p>","DOI":"10.3389\/fphar.2026.1917467","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:40:53Z","timestamp":1786606853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota and the gut\u2013liver axis in MASLD: mechanisms, immune regulation and therapeutic opportunities"],"prefix":"10.3389","volume":"17","author":[{"given":"Jingjing","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjun","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/liv.14453","article-title":"Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"40","author":"Adams","year":"2020","journal-title":"Liver Int."},{"key":"B2","first-page":"167","article-title":"Correlation of short chain fatty acid (SCFA) levels with transient elastography values and controlled attenuation parameters in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"57","author":"Astari","year":"2025","journal-title":"Acta Med. Indones."},{"key":"B3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/19490976.2019.1681861","article-title":"Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis","volume":"11","author":"Astbury","year":"2020","journal-title":"Gut Microbes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejphar.2019.01.039","article-title":"Evaluating the therapeutic potential of one-carbon donors in nonalcoholic fatty liver disease","volume":"847","author":"Bakir","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.26225","article-title":"Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis","volume":"57","author":"Bechmann","year":"2013","journal-title":"Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett","year":"2013","journal-title":"Cell Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","article-title":"Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin","volume":"48","author":"Bergheim","year":"2008","journal-title":"J. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00125-017-4209-3","article-title":"Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice","volume":"60","author":"Blasco-Baque","year":"2017","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e70093","DOI":"10.1111\/ijpo.70093","article-title":"Endotoxin markers are elevated in adolescents with obesity with and without metabolic dysfunction-associated steatotic liver disease","volume":"21","author":"Boone","year":"2026","journal-title":"Pediatr. Obes."},{"key":"B11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/CS20130833","article-title":"CXCR4 dysfunction in non-alcoholic steatohepatitis in mice and patients","volume":"128","author":"Boujedidi","year":"2015","journal-title":"Clin. Sci. (Lond)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/microorganisms9010199","article-title":"Fecal microbiota transplant from human to mice gives insights into the role of the gut microbiota in non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Burz","year":"2021","journal-title":"Microorganisms"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0299946","DOI":"10.1371\/journal.pone.0299946","article-title":"Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: an updated systematic review and meta-analysis","volume":"19","author":"Cai","year":"2024","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"102759","DOI":"10.1016\/j.ebiom.2020.102759","article-title":"Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes","volume":"55","author":"Calderon","year":"2020","journal-title":"EBioMedicine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"key":"B19","first-page":"197","article-title":"Modulation of gut microbiota by berberine improves steatohepatitis in high-fat diet-fed BALB\/C mice","volume":"19","author":"Cao","year":"2016","journal-title":"Arch. Iran. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.23736\/s2724-5985.23.03361-2","article-title":"Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease","volume":"70","author":"Castelnuovo","year":"2024","journal-title":"Minerva Gastroenterol. (Torino)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"153693","DOI":"10.1016\/j.phymed.2021.153693","article-title":"A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation","volume":"91","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/gutjnl-2018-316307","article-title":"Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease","volume":"68","author":"Chu","year":"2019","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/hepr.12904","article-title":"Rifaximin in non-alcoholic steatohepatitis: an open-label pilot study","volume":"48","author":"Cobbold","year":"2018","journal-title":"Hepatol. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12263-012-0300-z","article-title":"Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet","volume":"8","author":"Cordero","year":"","journal-title":"Genes Nutr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ymgme.2013.08.022","article-title":"Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: effect of dietary methyl donor supplementation","volume":"110","author":"Cordero","year":"","journal-title":"Mol. Genet. Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"21307","DOI":"10.1073\/pnas.1215689109","article-title":"Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme","volume":"109","author":"Craciun","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1021\/cb500113p","article-title":"Characterization of choline trimethylamine-lyase expands the chemistry of glycyl radical enzymes","volume":"9","author":"Craciun","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","article-title":"Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance","volume":"8","author":"Da Silva","year":"2018","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e57387","DOI":"10.1371\/journal.pone.0057387","article-title":"Hepatic methionine homeostasis is conserved in C57BL\/6N mice on high-fat diet despite major changes in hepatic one-carbon metabolism","volume":"8","author":"Dahlhoff","year":"2013","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e12096","DOI":"10.1590\/1414-431x2022e12096","article-title":"The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats","volume":"55","author":"Dai","year":"2022","journal-title":"Braz J. Med. Biol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"15648","DOI":"10.1038\/s41598-018-33928-4","article-title":"Diet induced obesity is independent of metabolic endotoxemia and TLR4 signalling, but markedly increases hypothalamic expression of the acute phase protein, SerpinA3N","volume":"8","author":"Dalby","year":"2018","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"13729","DOI":"10.1038\/srep13729","article-title":"Effect of miR-34a in regulating steatosis by targeting PPAR\u03b1 expression in nonalcoholic fatty liver disease","volume":"5","author":"Ding","year":"2015","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jhep.2006.12.012","article-title":"The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population","volume":"46","author":"Dong","year":"2007","journal-title":"J. Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0166048","DOI":"10.1371\/journal.pone.0166048","article-title":"Pro-inflammatory cytokines but not endotoxin-related parameters associate with disease severity in patients with NAFLD","volume":"11","author":"du Plessis","year":"2016","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2014-308379","article-title":"Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease","volume":"65","author":"Engstler","year":"2016","journal-title":"Gut"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/ajcn\/85.5.1275","article-title":"Sex and menopausal status influence human dietary requirements for the nutrient choline","volume":"85","author":"Fischer","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"13484","DOI":"10.1038\/s41598-022-16754-7","article-title":"Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis","volume":"12","author":"Fred","year":"2022","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","article-title":"Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae","volume":"14","author":"Gan","year":"2023","journal-title":"Nat. Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/hep.29646","article-title":"Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis","volume":"67","author":"Garc\u00eda-Lezana","year":"2018","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-Farnesoid X receptor axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2541035","DOI":"10.1080\/19490976.2025.2541035","article-title":"Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial","volume":"17","author":"Groenewegen","year":"2025","journal-title":"Gut Microbes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3945\/ajcn.111.020156","article-title":"Choline intake in a large cohort of patients with nonalcoholic fatty liver disease","volume":"95","author":"Guerrerio","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1055\/s-0042-1748037","article-title":"Intestinal barrier dysfunction in fatty liver disease: roles of microbiota, mucosal immune system, and bile acids","volume":"42","author":"Gupta","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","article-title":"Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma","volume":"74","author":"Ha","year":"2024","journal-title":"Gut"},{"key":"B53","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42255-019-0076-1","article-title":"Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution","volume":"1","author":"Haas","year":"2019","journal-title":"Nat. Metab."},{"key":"B54","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/hep.0000000000000985","article-title":"Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1\u03b1","volume":"82","author":"Hai","year":"2025","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3892\/etm.2018.6300","article-title":"2,3,5,4\u2019-tetrahydroxy-stilbene-2-O-\u03b2-D-glucoside attenuates methionine and choline-deficient diet-induced non-alcoholic fatty liver disease","volume":"16","author":"Han","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated endotoxin levels in non-alcoholic fatty liver disease","volume":"7","author":"Harte","year":"2010","journal-title":"J. Inflamm. (London)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"E320","DOI":"10.1111\/hepr.12992","article-title":"Identification of the genomic region under epigenetic regulation during non-alcoholic fatty liver disease progression","volume":"48","author":"Hotta","year":"2018","journal-title":"Hepatol. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1500293","DOI":"10.3389\/fnut.2025.1500293","article-title":"Fecal microbiota transplantation improves hepatic steatosis induced by HFD in a mouse model associated with liver ILC1 regulation and indole-3-carbinol level","volume":"12","author":"Hou","year":"2025","journal-title":"Front. Nutr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.3390\/nu13113725","article-title":"Gut microbiota reshaped by Pectin treatment improves liver steatosis in Obese mice","volume":"13","author":"Houron","year":"2021","journal-title":"Nutrients"},{"key":"B61","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/00365528209182070","article-title":"Absorption of short-chain fatty acids from the human colon measured by the 14CO2 breath test","volume":"17","author":"H\u00f8verstad","year":"1982","journal-title":"Scand. J. Gastroenterol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"803445","DOI":"10.3389\/fphys.2022.803445","article-title":"MicroRNA-122-5p inhibition improves inflammation and oxidative stress damage in dietary-induced non-alcoholic fatty liver disease through targeting FOXO3","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11845-023-03529-w","article-title":"MicroRNA-582-3p knockdown alleviates non-alcoholic steatohepatitis by altering the gut microbiota composition and moderating TMBIM1","volume":"193","author":"Huang","year":"2024","journal-title":"Ir. J. Med. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","article-title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases","volume":"28","author":"Ianiro","year":"2022","journal-title":"Nat. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12986-018-0323-6","article-title":"Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice","volume":"15","author":"Jia","year":"2018","journal-title":"Nutr. Metab. (London)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2309683","DOI":"10.1080\/19490976.2024.2309683","article-title":"Phocaeicola vulgatus alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA","volume":"16","author":"Jin","year":"2024","journal-title":"Gut Microbes"},{"key":"B69","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1900995","article-title":"Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment","volume":"13","author":"Kang","year":"2021","journal-title":"Gut Microbes"},{"key":"B71","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bbrc.2005.01.139","article-title":"Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1","volume":"329","author":"Katsuma","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.ajcnut.2025.04.018","article-title":"Short-chain fatty acid kinetics and concentrations are higher after inulin supplementation in young and older adults: a randomized trial","volume":"121","author":"Kirschner","year":"2025","journal-title":"Am. J. Clin. Nutr."},{"key":"B73","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4254\/wjh.v15.i2.208","article-title":"Clostridioides difficile infection in patients with nonalcoholic fatty liver disease-current status","volume":"15","author":"Kiseleva","year":"2023","journal-title":"World J. Hepatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jhep.2015.02.049","article-title":"Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease","volume":"63","author":"Kitamoto","year":"2015","journal-title":"J. Hepatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","article-title":"A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial","volume":"27","author":"Kobyliak","year":"2018","journal-title":"J. Gastrointestin Liver Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jhep.2023.04.037","article-title":"Intestinal B cells license metabolic T-cell activation in NASH microbiota\/antigen-independently and contribute to fibrosis by IgA-FcR signalling","volume":"79","author":"Kotsiliti","year":"2023","journal-title":"J. Hepatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.molcel.2016.10.025","article-title":"Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues","volume":"64","author":"Krautkramer","year":"2016","journal-title":"Mol. Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.dld.2023.06.015","article-title":"Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH","volume":"55","author":"Lee","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur. J. Intern Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e162291","DOI":"10.1172\/jci162291","article-title":"Effect of acute TLR4 inhibition on insulin resistance in humans","volume":"132","author":"Liang","year":"2022","journal-title":"J. Clin. Invest"},{"key":"B84","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1055\/s-0043-125066","article-title":"Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signaling pathway","volume":"126","author":"Liu","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e0262855","DOI":"10.1371\/journal.pone.0262855","article-title":"Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency","volume":"17","author":"Liu","year":"2022","journal-title":"PLoS One"},{"key":"B86","first-page":"452","article-title":"Intestinal barrier function in the pathogenesis of nonalcoholic fatty liver disease","volume":"11","author":"Liu","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/biology13040243","article-title":"Intestinal barrier dysfunction and gut microbiota in non-alcoholic fatty liver disease: assessment, mechanisms, and therapeutic considerations","volume":"13","author":"Long","year":"","journal-title":"Biol. (Basel)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e0310","DOI":"10.1097\/hc9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Long","year":"","journal-title":"Hepatol. Commun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPAR\u03b1 expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"key":"B90","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.chom.2025.04.020","article-title":"Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: function, mechanism, and therapeutic prospects","volume":"33","author":"Luo","year":"2025","journal-title":"Cell Host Microbe"},{"key":"B91","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"B92","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2672.1992.tb04882.x","article-title":"Comparison of fermentation reactions in different regions of the human colon","volume":"72","author":"Macfarlane","year":"1992","journal-title":"J. Appl. Bacteriol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3350\/cmh.2024.0229","article-title":"DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Magdy","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.chom.2018.03.011","article-title":"Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids","volume":"23","author":"Martinez-Guryn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/oby.23711","article-title":"Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: a case-control study","volume":"31","author":"Mart\u00ednez-Montoro","year":"2023","journal-title":"Obes. (Silver Spring)"},{"key":"B96","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/medsci14020300","article-title":"Treatment of small intestinal bacterial overgrowth (SIBO) in gastrointestinal, hepatic, endocrine, neurological, and postoperative diseases: a comprehensive narrative review","volume":"14","author":"Maslennikov","year":"2026","journal-title":"Med. Sci. (Basel)"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.3390\/cells11213390","article-title":"Endogenous ethanol and triglyceride production by gut Pichia kudriavzevii, Candida albicans and Candida glabrata yeasts in non-alcoholic steatohepatitis","volume":"11","author":"Mbaye","year":"2022","journal-title":"Cells"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1279354","DOI":"10.3389\/fcimb.2023.1279354","article-title":"Increased fecal ethanol and enriched ethanol-producing gut bacteria Limosilactobacillus fermentum, Enterocloster bolteae, Mediterraneibacter gnavus and Streptococcus mutans in nonalcoholic steatohepatitis","volume":"13","author":"Mbaye","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/gut.19.9.819","article-title":"Short chain fatty acid absorption by the human large intestine","volume":"19","author":"McNeil","year":"1978","journal-title":"Gut"},{"key":"B100","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41575-024-00937-w","article-title":"Endogenous ethanol production in health and disease","volume":"21","author":"Meijnikman","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/s41591-022-02016-6","article-title":"Microbiome-derived ethanol in nonalcoholic fatty liver disease","volume":"28","author":"Meijnikman","year":"2022","journal-title":"Nat. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J. Hepatol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e0151829","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e0183282","DOI":"10.1371\/journal.pone.0183282","article-title":"Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: studies in children","volume":"12","author":"Nier","year":"2017","journal-title":"PLoS One"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/nu13031013","article-title":"Characterization of gut microbiome in Korean patients with metabolic associated fatty liver disease","volume":"13","author":"Oh","year":"2021","journal-title":"Nutrients"},{"key":"B107","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5152\/tjg.2017.17033","article-title":"Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis","volume":"28","author":"\u00d6zkul","year":"2017","journal-title":"Turk J. Gastroenterol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ebiom.2019.02.023","article-title":"Bacterial viability in faecal transplants: which bacteria survive?","volume":"41","author":"Papanicolas","year":"2019","journal-title":"EBioMedicine"},{"key":"B109","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","article-title":"Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease","volume":"62","author":"Pirola","year":"2013","journal-title":"Gut"},{"key":"B111","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/nu16111668","article-title":"Implications of microbiota and immune system in development and progression of metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Popov","year":"2024","journal-title":"Nutrients"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e1800930","DOI":"10.1002\/mnfr.201800930","article-title":"Functional interactions between gut microbiota transplantation, quercetin, and high-fat diet determine non-alcoholic fatty liver disease development in germ-free mice","volume":"63","author":"Porras","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"108764","DOI":"10.1016\/j.isci.2023.108764","article-title":"Collinsella aerofaciens linked with increased ethanol production and liver inflammation contribute to the pathophysiology of NAFLD","volume":"27","author":"Purohit","year":"2024","journal-title":"iScience"},{"key":"B115","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of junctional adhesion molecule A promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40168-017-0271-9","article-title":"Uncovering the trimethylamine-producing bacteria of the human gut microbiota","volume":"5","author":"Rath","year":"2017","journal-title":"Microbiome"},{"key":"B117","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J. Hepatol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cmet.2016.06.016","article-title":"Effects of gut microbiota manipulation by antibiotics on host metabolism in Obese humans: a randomized double-blind placebo-controlled trial","volume":"24","author":"Reijnders","year":"2016","journal-title":"Cell Metab."},{"key":"B119","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1194\/jlr.M020313","article-title":"Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7\u03b1-dehydroxylating intestinal bacterium","volume":"53","author":"Ridlon","year":"2012","journal-title":"J. Lipid Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/hep.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"B122","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fmicb.2020.00973","article-title":"An overview on fecal branched short-chain fatty acids along human life and as related with body mass index: associated dietary and anthropometric factors","volume":"11","author":"Rios-Covian","year":"2020","journal-title":"Front. Microbiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e80169","DOI":"10.1371\/journal.pone.0080169","article-title":"Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice","volume":"9","author":"Ritze","year":"2014","journal-title":"PLoS One"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e02481","DOI":"10.1128\/mBio.02481-14","article-title":"Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide","volume":"6","author":"Romano","year":"2015","journal-title":"mBio"},{"key":"B125","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1002\/hep.32043","article-title":"Global microbiota-dependent histone acetylation patterns are irreversible and independent of short chain fatty acids","volume":"74","author":"Saiman","year":"2021","journal-title":"Hepatology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1053\/j.gastro.2020.01.031","article-title":"Synbiotics alter fecal microbiomes, but not liver fat or fibrosis, in a randomized trial of patients with nonalcoholic fatty liver disease","volume":"158","author":"Scorletti","year":"2020","journal-title":"Gastroenterol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0171-9335(98)80065-4","article-title":"The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin","volume":"75","author":"Scudamore","year":"1998","journal-title":"Eur. J. Cell Biol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"609060","DOI":"10.3389\/fimmu.2020.609060","article-title":"TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/jgh.16359","article-title":"Hepatobiliary and pancreatic: multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota","volume":"38","author":"Shou","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","volume":"76","author":"Smirnova","year":"2022","journal-title":"Hepatology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"B132","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/apt.17629","article-title":"Detection of changes in regional colonic fermentation in response to supplementing a low FODMAP diet with dietary fibres by hydrogen concentrations, but not by luminal pH","volume":"58","author":"So","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1096\/fj.04-3580com","article-title":"Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)","volume":"19","author":"Song","year":"2005","journal-title":"Faseb J."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","article-title":"Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"79","author":"Song","year":"2023","journal-title":"J. Hepatol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.cgh.2022.11.030","article-title":"Blood endotoxin levels as biomarker of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Soppert","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","article-title":"FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis","volume":"71","author":"Sorribas","year":"2019","journal-title":"J. Hepatol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1126\/science.aad0135","article-title":"A gut-vascular barrier controls the systemic dissemination of bacteria","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"B138","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","article-title":"Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency","volume":"140","author":"Spencer","year":"2011","journal-title":"Gastroenterology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2223330","DOI":"10.1080\/19490976.2023.2223330","article-title":"Faecal microbiota transplantation affects liver DNA methylation in non-alcoholic fatty liver disease: a multi-omics approach","volume":"15","author":"Stols-Gon\u00e7alves","year":"2023","journal-title":"Gut Microbes"},{"key":"B140","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/FPC.0000000000000193","article-title":"Phosphatidylethanolamine N-methyltransferase gene rs7946 polymorphism plays a role in risk of nonalcoholic fatty liver disease: evidence from meta-analysis","volume":"26","author":"Tan","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e1900257","DOI":"10.1002\/mnfr.201900257","article-title":"Trimethylamine N-Oxide aggravates liver steatosis through modulation of bile acid metabolism and inhibition of Farnesoid X receptor signaling in nonalcoholic fatty liver disease","volume":"63","author":"Tan","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12876-024-03129-7","article-title":"Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease","volume":"24","author":"Thing","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab."},{"key":"B144","doi-asserted-by":"publisher","first-page":"eaav0120","DOI":"10.1126\/scitranslmed.aav0120","article-title":"The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans","volume":"11","author":"Tirosh","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/nu15071712","article-title":"Circulating short-chain fatty acids and non-alcoholic fatty liver disease severity in patients with type 2 diabetes mellitus","volume":"15","author":"Tsai","year":"2023","journal-title":"Nutrients"},{"key":"B146","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/MCG.0b013e3181e12c24","article-title":"Novel evidence for chronic exposure to endotoxin in human nonalcoholic steatohepatitis","volume":"45","author":"Verdam","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1644014","DOI":"10.3389\/fnut.2025.1644014","article-title":"Multi-omics integration reveals the impact of mediterranean diet on hepatic metabolism and gut microbiota in mice with metabolic dysfunction-associated steatotic liver disease","volume":"12","author":"Wang","year":"2025","journal-title":"Front. Nutr."},{"key":"B148","doi-asserted-by":"publisher","first-page":"108363","DOI":"10.1016\/j.jnutbio.2020.108363","article-title":"Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis","volume":"81","author":"Wang","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"B149","doi-asserted-by":"publisher","first-page":"2234695","DOI":"10.1155\/2021\/2234695","article-title":"Structural and functional modulation of gut microbiota by Jiangzhi granules during the amelioration of nonalcoholic fatty liver disease","volume":"2021","author":"Wang","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"B150","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.ade0522","article-title":"The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9","volume":"381","author":"Wang","year":"2023","journal-title":"Science"},{"key":"B151","doi-asserted-by":"publisher","first-page":"123211","DOI":"10.1016\/j.lfs.2024.123211","article-title":"Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"359","author":"Wang","year":"2024","journal-title":"Life Sci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1341938","DOI":"10.3389\/fmicb.2024.1341938","article-title":"Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions","volume":"15","author":"Wei","year":"2024","journal-title":"Front. Microbiol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ajg.2013.92","article-title":"Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome","volume":"108","author":"Wilcz-Villega","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40168-021-01060-7","article-title":"Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity","volume":"9","author":"Wilson","year":"2021","journal-title":"Microbiome"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor fecal microbiota transplantation alters gut microbiota and metabolites in Obese individuals with steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol. Commun."},{"key":"B156","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41586-020-2604-2","article-title":"Microbiota-derived metabolite promotes HDAC3 activity in the gut","volume":"586","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"B157","first-page":"136","article-title":"Expression of intestinal tight junction proteins in patients with non-alcoholic fatty liver disease","volume":"61","author":"Xin","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"B158","doi-asserted-by":"publisher","first-page":"759306","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"104560","DOI":"10.1016\/j.ebiom.2023.104560","article-title":"Three Klebsiella species as potential pathobionts generating endogenous ethanol in a clinical cohort of patients with auto-brewery syndrome: a case control study","volume":"91","author":"Xue","year":"2023","journal-title":"EBioMedicine"},{"key":"B160","doi-asserted-by":"publisher","first-page":"913378","DOI":"10.3389\/fphar.2022.913378","article-title":"Berberrubine, a main metabolite of berberine, alleviates non-alcoholic fatty liver disease via modulating glucose and lipid metabolism and restoring gut microbiota","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41522-023-00451-y","article-title":"Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid","volume":"9","author":"Yang","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B162","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/S0021-9258(18)69166-5","article-title":"The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes","volume":"263","author":"Yao","year":"1988","journal-title":"J. Biol. Chem."},{"key":"B163","doi-asserted-by":"publisher","first-page":"156992","DOI":"10.1016\/j.phymed.2025.156992","article-title":"Alisol B ameliorated metabolic dysfunction-associated steatotic liver disease via regulating purine metabolism and restoring the gut microbiota disorders","volume":"145","author":"Yiyou","year":"2025","journal-title":"Phytomedicine"},{"key":"B164","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cpdd.790","article-title":"Pharmacokinetics and pharmacodynamics of ursodeoxycholic acid in an overweight population with abnormal liver function","volume":"10","author":"Yoon","year":"2021","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B167","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab."},{"key":"B168","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12916-024-03317-y","article-title":"Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"154444","DOI":"10.1016\/j.phymed.2022.154444","article-title":"Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling","volume":"107","author":"Zhai","year":"2022","journal-title":"Phytomedicine"},{"key":"B170","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13238-019-00684-8","article-title":"Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening","volume":"11","author":"Zhang","year":"2020","journal-title":"Protein Cell"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/1440-1681.13497","article-title":"Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression","volume":"48","author":"Zhang","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/nm.4334","article-title":"Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4","volume":"23","author":"Zhao","year":"2017","journal-title":"Nat. Med."},{"key":"B173","first-page":"2385","article-title":"Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats","volume":"33","author":"Zheng","year":"2008","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B174","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41401-022-00921-7","article-title":"Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity","volume":"44","author":"Zhong","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"B175","doi-asserted-by":"publisher","first-page":"2372881","DOI":"10.1080\/19490976.2024.2372881","article-title":"Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16\/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease","volume":"16","author":"Zhong","year":"2024","journal-title":"Gut Microbes"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","article-title":"Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"B177","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1042\/BJ20021523","article-title":"Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline","volume":"370","author":"Zhu","year":"2003","journal-title":"Biochem. J."},{"key":"B178","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jth.14234","article-title":"Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk","volume":"16","author":"Zhu","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"B180","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.3390\/cells11244133","article-title":"Lactobacillus salivarius SNK-6 regulates liver lipid metabolism partly via the miR-130a-5p\/MBOAT2 pathway in a NAFLD model of laying hens","volume":"11","author":"Zhu","year":"2022","journal-title":"Cells"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1917467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:40:56Z","timestamp":1786606856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1917467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":180,"alternative-id":["10.3389\/fphar.2026.1917467"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1917467","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"1917467"}}